Stanley Druckenmiller, a multi-billionaire investor has invested more than one billion dollars in three stocks that are not widely known.
The Duquesne Family Office of Druckenmiller is betting heavily on the healthcare and tech sectors, according to new filings.
The firm has the largest stake in Natera Inc., a technology company that specializes in early genetic detection for hereditary diseases such as cancer. Duquesne owns about $521.48m worth of NTRA stock, according to data.
It also has a significant stake in Teva Pharmaceutic Industries (TEVA), based in Israel, a manufacturer of generic drugs. Duquesne, according to its filings, has accumulated 14.889 million shares in TEVA valued at approximately $252.955 millions.
Druckenmiller also has a large investment in Coupang Inc., a South Korean ecommerce giant. The company owns more than 9,3 million shares in CPNG, worth approximately $252.659 millions.
Duquesne Family Office has a total of more than $1.0 billion in shares of NTRA, TEVA, and CPNG. This represents 33% of its $3.06 billion investment portfolio.
As of the first quarter of 2018, Druckenmiller’s largest holdings included Woodward Inc., worth $226.13 millions, Philip Morris International, worth $193.67million, and Coherent, worth $175.27million.
In Q1 of 2025, however, it reduced its stakes in United Airlines (UAL), United Airlines Canada (UAL), United Airlines Canada (SKX), and SLM Corp. (SLM).
Please follow us at X@InvCryptoDaily
Subscribe for email alerts to avoid missing a beat
___________________
___________________
Sources of Images include Pixabay Creative Commons & Midjourney
The post Billionaire Stanley Druckenmiller Allocates $1,027.090.408 to Three Under-the-Radar Securities may be updated as new information becomes available.
This site is for entertainment only. Click here to read more
